Firefly Neuroscience, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $20.4M
- Price
- $1.15
- % Change (Daily % change from the live per-ticker quote feed.)
- -4.17%
- Volume
- 88.4K
About
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.
Quick stats
Shares outstanding15.6M
Computed float14.7M
Float / shares94.2%
Key info
SectorTechnology
IndustrySoftware - Application
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0000803578
Websitehttps://fireflyneuro.com
AI Summary
AI-generated1/8
standardbullishpartnership
Firefly Neuroscience’s Evoke™ Platform Selected to Bring Objective Brain-Function Insights to Radial’s AI-Native Operating System for Brain Medicine
Firefly Neuroscience announced a strategic collaboration with Radial, operator of the country's largest network of brain medicine clinics, to pursue integrating Firefly's FDA 510(k)-cleared, AI-powered Evoke EEG/ERP platform into RadialOS, Radial's AI-native operating system for brain medicine.
Radial's network spans 27 clinics in seven states with more than 100 clinicians and accepts most major insurance plans including Medicare; the company is backed by General Catalyst and recently expanded via its August 2026 acquisition of the management services organization supporting Mindful Health Solutions.
No financial terms, deployment timeline, or committed volumes were disclosed, and the integration is described as planned rather than live, so the commercial impact for Firefly remains prospective.
Red flags
- No financial terms, revenue commitments, or deployment timeline disclosed for the collaboration
- Integration is at the planned/pursuit stage, not yet operational; benefits are forward-looking